Sphingosine-1-phosphate attenuates seizures and cognitive deficits, associated with reduced hippocampal IL-1β in a PTZ-induced epilepsy model

Key Points

Seizures and cognitive deficits are significantly reduced by sphingosine-1-phosphate in the epilepsy model.
Key evidence indicates a direct association with reduced IL-1β levels; IL-1β is a marker of neuroinflammation.
Observational analysis of PTZ-induced epilepsy models revealed neuroprotective effects of sphingosine-1-phosphate.
Findings may enable new therapeutic strategies, though mouse model limits further translational efforts.

Abstract

S1P exerts anti-seizure and neuroprotective effects in PTZ-induced epileptic mice and attenuates IL-1β-mediated neuroinflammation. These findings suggest that the S1P-IL-1β axis may represent a promising therapeutic target for epilepsy and its associated cognitive impairments.

Sphingosine-1-phosphate attenuates seizures and cognitive deficits, associated with reduced hippocampal IL-1β in a PTZ-induced epilepsy model

Key Points

Abstract

Cite This Study